CD274 and small cell lung carcinoma: Anti-programmed cell death-1 (anti-PD-1)/anti-programmed cell death ligand-1 (anti-PD-L1) immune checkpoint inhibitors have been incorporated into treatment algorithms for advanced SCLC [34].